Loading
HKSEHealthcareMedical - Devices
Latest quote
HK$7.875
+HK$0.01 · +0.13%
Beijing Chunlizhengda Medical Instruments Co., Ltd. functions as a prominent entity within the orthopedic medical device industry, dedicated to the development, manufacturing, and distribution of surgical implants, instruments, and associated medical supplies throughout the People's Republic of China. Its core product range features implantable orthopedic solutions, specifically comprising joint prostheses and spinal treatment products. The company predominantly distributes its merchandise via an expansive network of distributors, through original design manufacturing (ODM) and original equipment manufacturing (OEM) partnerships under the 'Chunli' label, and by direct sales to healthcare institutions. Beyond its domestic operations, the firm also engages in exporting its products to various countries globally. Established in 1998, its corporate headquarters are situated in Beijing, China.
Latest quote
HK$7.875
+HK$0.01 · +0.13%
Regular session · HKT · Market data may be delayed.
Beijing Chunlizhengda Medical Instruments Co., Ltd. functions as a prominent entity within the orthopedic medical device industry, dedicated to the development, manufacturing, and distribution of surgical implants, instruments, and associated medical supplies throughout the People's Republic of China. Its core product range features implantable orthopedic solutions, specifically comprising joint prostheses and spinal treatment products. The company predominantly distributes its merchandise via an expansive network of distributors, through original design manufacturing (ODM) and original equipment manufacturing (OEM) partnerships under the 'Chunli' label, and by direct sales to healthcare institutions. Beyond its domestic operations, the firm also engages in exporting its products to various countries globally. Established in 1998, its corporate headquarters are situated in Beijing, China.
Day range
Current HK$7.875
52-week range
Current HK$7.875
Regular session · HKT · Market data may be delayed.
Beijing Chunlizhengda Medical Instruments Co., Ltd. functions as a prominent entity within the orthopedic medical device industry, dedicated to the development, manufacturing, and distribution of surgical implants, instruments, and associated medical supplies throughout the People's Republic of China. Its core product range features implantable orthopedic solutions, specifically comprising joint prostheses and spinal treatment products. The company predominantly distributes its merchandise via an expansive network of distributors, through original design manufacturing (ODM) and original equipment manufacturing (OEM) partnerships under the 'Chunli' label, and by direct sales to healthcare institutions. Beyond its domestic operations, the firm also engages in exporting its products to various countries globally. Established in 1998, its corporate headquarters are situated in Beijing, China.
Day range
Current HK$7.875
52-week range
Current HK$7.875
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.05B CNY | 805.86M CNY | 1.21B CNY | 1.2B CNY | 1.11B CNY |
| Cost of goods sold | 392.37M CNY | 289.37M CNY | 332.64M CNY | 288.08M CNY | 253.6M CNY |
| Gross profit | 653.4M CNY | 516.49M CNY | 875.89M CNY | 913.53M CNY | 854.54M CNY |
| Research and development | 118.5M CNY | 133.1M CNY | 157.45M CNY | 162.34M CNY | 104.84M CNY |
| Selling, general, and administrative | 137.91M CNY | 285.54M CNY | 279.17M CNY | 299.84M CNY | 352.74M CNY |
| Operating expenses | 351.15M CNY | 406.19M CNY | 569.91M CNY | 581.19M CNY | 476.43M CNY |
| Interest income | 14.88M CNY | 16.31M CNY | 14.46M CNY | 16.86M CNY | 10.76M CNY |
| Interest expense | 200.95K CNY | 44.94K CNY | 364.86K CNY | 46.73K CNY | 256.55K CNY |
| Depreciation and amortization | 39.16M CNY | 37.68M CNY | 34.66M CNY | 30.03M CNY | 16.55M CNY |
| Operating income | 302.25M CNY | 130.71M CNY | 305.98M CNY | 328.91M CNY | 367.59M CNY |
| Net income | 272.54M CNY | 124.99M CNY | 277.82M CNY | 307.72M CNY | 322.36M CNY |
Company facts updated Sep 12, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS1.5M0.00%646.2B USD0.05%$87.14+1.00%
Vanguard FTSE Emerging Markets ETFVWO1.39M0.00%162.3B USD0.06%$60.35+0.69%
Global X - Aging Population ETFAGNG158.13K0.17%90.29M USD0.50%$36.5894-0.24%
State Street SPDR S&P Emerging Markets Small Cap ETFEWX109.83K0.02%684.6M USD0.65%$72.61+0.30%
Vanguard Total World Stock ETFVT74.77K0.00%97.9B USD0.06%$159.94+0.89%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS70.72K0.00%13.6B USD0.06%$158.56+0.72%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM48.4K0.00%9.62B USD0.39%$40.53+1.12%
Avantis Emerging Markets Equity ETFAVEM48.07K—28.6B USD0.33%$95.35+1.29%Vanguard Total International Stock ETFVXUSVanguard FTSE Emerging Markets ETFVWOGlobal X - Aging Population ETFAGNGState Street SPDR S&P Emerging Markets Small Cap ETFEWXVanguard Total World Stock ETFVTVanguard FTSE All-World ex-US Small-Cap ETFVSSDimensional - Emerging Markets Core Equity 2 ETFDFEMAvantis Emerging Markets Equity ETFAVEMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
